Basel Medical Group Ltd (BMGL)

Basel Medical Group Statistics

Total Valuation

BMGL has a market cap or net worth of $13.26 million. The enterprise value is $9.61 million.

Market Cap	13.26M
Enterprise Value	9.61M

Important Dates

The last earnings date was Tuesday, November 4, 2025, before market open.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BMGL has 18.79 million shares outstanding. The number of shares has increased by 15.61% in one year.

Current Share Class	18.79M
Shares Outstanding	18.79M
Shares Change (YoY)	+15.61%
Shares Change (QoQ)	+31.21%
Owned by Insiders (%)	13.65%
Owned by Institutions (%)	0.98%
Float	6.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.40
Forward PS	n/a
PB Ratio	3.35
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 1.04.

Current Ratio	1.23
Quick Ratio	1.15
Debt / Equity	1.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.08

Financial Efficiency

Return on equity (ROE) is -194.56% and return on invested capital (ROIC) is -977.21%.

Return on Equity (ROE)	-194.56%
Return on Assets (ROA)	-4.67%
Return on Invested Capital (ROIC)	-977.21%
Return on Capital Employed (ROCE)	-20.11%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$115,949
Profits Per Employee	-$115,765
Employee Count	82
Asset Turnover	0.73
Inventory Turnover	39.81

Taxes

Income Tax	-327,791
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.71
200-Day Moving Average	1.81
Relative Strength Index (RSI)	50.47
Average Volume (20 Days)	48,402

Short Selling Information

The latest short interest is 132,121, so 0.70% of the outstanding shares have been sold short.

Short Interest	132,121
Short Previous Month	137,536
Short % of Shares Out	0.70%
Short % of Float	2.20%
Short Ratio (days to cover)	2.36

Income Statement

In the last 12 months, BMGL had revenue of $9.51 million and -$9.49 million in losses. Loss per share was -$0.51.

Revenue	9.51M
Gross Profit	2.50M
Operating Income	-973,122
Pretax Income	-9.82M
Net Income	-9.49M
EBITDA	-888,574
EBIT	-973,122
Loss Per Share	-$0.51

Balance Sheet

The company has $7.70 million in cash and $3.98 million in debt, with a net cash position of $3.72 million or $0.20 per share.

Cash & Cash Equivalents	7.70M
Total Debt	3.98M
Net Cash	3.72M
Net Cash Per Share	$0.20
Equity (Book Value)	3.82M
Book Value Per Share	0.20
Working Capital	1.91M

Cash Flow

In the last 12 months, operating cash flow was -$3.41 million and capital expenditures -$8.67 million, giving a free cash flow of -$12.15 million.

Operating Cash Flow	-3.41M
Capital Expenditures	-8.67M
Free Cash Flow	-12.15M
FCF Per Share	-$0.65

Margins

Gross margin is 26.29%, with operating and profit margins of -10.23% and -99.84%.

Gross Margin	26.29%
Operating Margin	-10.23%
Pretax Margin	-103.29%
Profit Margin	-99.84%
EBITDA Margin	-9.35%
EBIT Margin	-10.23%
FCF Margin	n/a

Dividends & Yields

BMGL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.61%
Shareholder Yield	-15.61%
Earnings Yield	-71.22%
FCF Yield	-91.17%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMGL has an Altman Z-Score of 4.98 and a Piotroski F-Score of 2.

Altman Z-Score	4.98
Piotroski F-Score	2